British psychedelics company Eleusis will go public via a merger with Silver Spike Acquisition Corp. II (“SPKB”) SPKB, a special purpose acquisition company sponsored by an affiliate of Silver Spike ...
Psychedelic drugs like LSD have long been of interest in the medical community because of their anti-inflammatory properties. But efforts to transform them into therapeutics have been hampered by laws ...
When it comes to drug formulations, pills are generally preferred to injections and infusions. They’re more convenient for patients since dosing doesn’t require a ...
ST VINCENT AND THE GRENADINES, Caribbean, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Eleusis, the world’s first legal luxury psychedelic immersion, using DMTx protocols, will officially debut in March 2026 on ...
LONDON--(BUSINESS WIRE)-- Eleusis Holdings Ltd announced today it has received a Notice of Allowance for its proprietary psilocin salt form and accompanying formulations from the US Patent and ...
LONDON & NEW YORK--(BUSINESS WIRE)--Eleusis Ltd, a clinical-stage life science company dedicated to unlocking the full therapeutic potential of psychedelics, today announced that it has appointed ...
About Eleusis Founded in 2013, Eleusis is a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics. ELE-Psilo, Eleusis’s lead drug candidate, is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results